1. Executive Summary2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product Type: Market Size & Analysis
5.1. Overview
5.2. Consumables
5.3. Services
5.4. Software
6. Type: Market Size & Analysis
6.1. Overview
6.2. Safety Biomarkers
6.3. Efficacy Biomarkers
6.4. Predictive Biomarkers
6.5. Surrogate Biomarkers
6.6. Pharmacodynamics Biomarkers
6.7. Prognostic Biomarkers
6.8. Validation Biomarkers
7. Application: Market Size & Analysis
7.1. Overview
7.2. Diagnostics
7.3. Drug Discovery & Development
7.4. Personalized Medicine
7.5. Disease Risk Assessment
7.6. Other Applications
8. Disease Indication: Market Size & Analysis
8.1. Overview
8.2. Cancer
8.3. Infectious Diseases
8.4. Immune Disorders
8.5. Neurological Disorders
8.6. Cardiovascular Disorders
8.7. Other Disease Indications
9. Geography: Market Size & Analysis
9.1. Overview
9.2. North America (U.S., Mexico, Canada)
9.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
9.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
9.5. Latin America (Brazil, Argentina)
9.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution
11. Vendor Profiles
11.1. Ge Healthcare
11.1.1. Overview
11.1.2. Financial Overview
11.1.3. Product Offerings
11.1.4. Developments
11.1.5. Business Strategy
11.2. Bio-Rad Laboratories
11.2.1. Overview
11.2.2. Financial Overview
11.2.3. Product Offerings
11.2.4. Developments
11.2.5. Business Strategy
11.3. Eisai Co. Ltd.
11.3.1. Overview
11.3.2. Financial Overview
11.3.3. Product Offerings
11.3.4. Developments
11.3.5. Business Strategy
11.4. Abbott Laboratories, Inc.
11.4.1. Overview
11.4.2. Financial Overview
11.4.3. Product Offerings
11.4.4. Developments
11.4.5. Business Strategy
11.5. Thermo Fisher Scientific Inc.
11.5.1. Overview
11.5.2. Financial Overview
11.5.3. Product Offerings
11.5.4. Developments
11.5.5. Business Strategy
11.6. Agilent Technologies Inc.
11.6.1. Overview
11.6.2. Financial Overview
11.6.3. Product Offerings
11.6.4. Developments
11.6.5. Business Strategy
11.7. Roche Diagnostics Limited
11.7.1. Overview
11.7.2. Financial Overview
11.7.3. Product Offerings
11.7.4. Developments
11.7.5. Business Strategy
11.8. Aushon Biosystem
11.8.1. Overview
11.8.2. Financial Overview
11.8.3. Product Offerings
11.8.4. Developments
11.8.5. Business Strategy
11.9. Epistem Ltd.
11.9.1. Overview
11.9.2. Financial Overview
11.9.3. Product Offerings
11.9.4. Developments
11.9.5. Business Strategy
11.10. Siemens AG
11.10.1. Overview
11.10.2. Financial Overview
11.10.3. Product Offerings
11.10.4. Developments
11.10.5. Business Strategy
12. Analyst Opinion13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
List of Tables
Table 1. Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 2. Biomarkers Market Value for Consumables, by Geography, 2021-2030 (USD Billion)
Table 3. Biomarkers Market Value for Services, by Geography, 2021-2030 (USD Billion)
Table 4. Biomarkers Market Value for Software, by Geography, 2021-2030 (USD Billion)
Table 5. Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 6. Biomarkers Market Value for Safety Biomarkers, 2021-2030 (USD Billion)
Table 7. Biomarkers Market Value for Efficacy Biomarkers, by Geography, 2021-2030 (USD Billion)
Table 8. Biomarkers Market Value for Predictive Biomarkers, by Geography, 2021-2030 (USD Billion)
Table 9. Biomarkers Market Value for Surrogate Biomarkers, by Geography, 2021-2030 (USD Billion)
Table 10. Biomarkers Market Value for Pharmacodynamics Biomarkers, by Geography, 2021-2030 (USD Billion)
Table 11. Biomarkers Market Value for Validation Biomarkers, by Geography, 2021-2030 (USD Billion)
Table 12. Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 13. Biomarkers Market Value for Diagnostics, 2021-2030 (USD Billion)
Table 14. Biomarkers Market Value for Drug Discovery & Development, by Geography, 2021-2030 (USD Billion)
Table 15. Biomarkers Market Value for Personalized Medicine, by Geography, 2021-2030 (USD Billion)
Table 16. Biomarkers Market Value for Disease Risk Assessment, by Geography, 2021-2030 (USD Billion)
Table 17. Biomarkers Market Value for Others, by Geography, 2021-2030 (USD Billion)
Table 18. Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 19. Biomarkers Market Value for Cancer, 2021-2030 (USD Billion)
Table 20. Biomarkers Market Value for Infectious Diseases, by Geography, 2021-2030 (USD Billion)
Table 21. Biomarkers Market Value for Immune Disorders, by Geography, 2021-2030 (USD Billion)
Table 22. Biomarkers Market Value for Neurological Disorders, by Geography, 2021-2030 (USD Billion)
Table 23. Biomarkers Market Value for Cardiovascular Disorders, by Geography, 2021-2030 (USD Billion)
Table 24. North America Biomarkers Market Value, by Country, 2021-2030 (USD Billion)
Table 25. North America Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 26. North America Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 27. North America Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 28. U.S Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 29. U.S Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 30. U.S Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 31. U.S Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 32. Canada Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 33. Canada Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 34. Canada Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 35. Canada Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 36. Mexico Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 37. Mexico Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 38. Mexico Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 39. Mexico Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 40. Europe Biomarkers Market Value, by Country, 2021-2030 (USD Billion)
Table 41. Europe Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 42. Europe Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 43. Europe Biomarkers Market Value, End Use Industries, 2021-2030 (USD Billion)
Table 44. Europe Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 45. Germany Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 46. Germany Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 47. Germany Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 48. Germany Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 49. U.K Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 50. U.K Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 51. U.K Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 52. U.K Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 53. France Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 54. France Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 55. France Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 56. France Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 57. Italy Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 58. Italy Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 59. Italy Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 60. Italy Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 61. Spain Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 62. Spain Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 63. Spain Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 64. Spain Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 65. RoE Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 66. RoE Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 67. RoE Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 68. RoE Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 69. Asia-Pacific Biomarkers Market Value, by Country, 2021-2030 (USD Billion)
Table 70. Asia-Pacific Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 71. Asia-Pacific Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 72. Asia-Pacific Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 73. Asia-Pacific Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 74. China Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 75. China Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 76. China Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 77. China Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 78. India Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 79. India Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 80. India Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 81. India Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 82. Japan Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 83. Japan Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 84. Japan Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 85. Japan Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 86. Rest of APAC Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 87. Rest of APAC Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 88. Rest of APAC Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 89. Rest of APAC Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 90. Latin America Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 91. Latin America Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 92. Latin America Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 93. Latin America Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 94. Brazil Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 95. Brazil Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 96. Brazil Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 97. Brazil Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 98. Argentina Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 99. Argentina Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 100. Argentina Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 101. Argentina Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 102. Middle East and Africa Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 103. Middle East and Africa Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 104. Middle East and Africa Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 105. Middle East and Africa Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 106. Saudi Arabia Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 107. Saudi Arabia Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 108. Saudi Arabia Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 109. Saudi Arabia Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 110. UAE Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 111. UAE Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 112. UAE Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 113. UAE Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 114. Rest of Middle East and Africa Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Table 115. Rest of Middle East and Africa Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Table 116. Rest of Middle East and Africa Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Table 117. Rest of Middle East and Africa Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 118. GE Healthcare: Financials
Table 119. GE Healthcare: Products & Services
Table 120. GE Healthcare: Recent Developments
Table 121. Bio-Rad Laboratories: Financials
Table 122. Bio-Rad Laboratories: Products & Services
Table 123. Bio-Rad Laboratories: Recent Developments
Table 124. Eisai Co. Ltd.: Financials
Table 125. Eisai Co. Ltd.: Products & Services
Table 126. Eisai Co. Ltd.: Recent Developments
Table 127. Abbott Laboratories, Inc.: Financials
Table 128. Abbott Laboratories, Inc.: Products & Services
Table 129. Abbott Laboratories, Inc.: Recent Developments
Table 130. Thermo Fisher Scientific Inc.: Financials
Table 131. Thermo Fisher Scientific Inc.: Products & Services
Table 132. Thermo Fisher Scientific Inc.: Recent Developments
Table 133. Agilent Technologies Inc.: Financials
Table 134. Agilent Technologies Inc.: Products & Services
Table 135. Agilent Technologies Inc.: Recent Developments
Table 136. Roche Diagnostics Limited: Financials
Table 137. Roche Diagnostics Limited: Products & Services
Table 138. Roche Diagnostics Limited: Developments
Table 139. Aushon Biosystem: Financials
Table 140. Aushon Biosystem: Products & Services
Table 141. Aushon Biosystem: Recent Developments
Table 142. Epistem Ltd.: Financials
Table 143. Epistem Ltd.: Products & Services
Table 144. Epistem Ltd.: Recent Developments
Table 145. Siemens AG: Financials
Table 146. Siemens AG: Products & Services
Table 147. Siemens AG: Recent Developments
List of Charts
Chart. 1. Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 2. Biomarkers Market Value for Consumables, by Geography , 2021-2030 (USD Billion)
Chart. 3. Biomarkers Market Value for Services, by Geography, 2021-2030 (USD Billion)
Chart. 4. Biomarkers Market Value for Software, by Geography, 2021-2030 (USD Billion)
Chart. 5. Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 6. Biomarkers Market Value for Safety Biomarkers, 2021-2030 (USD Billion)
Chart. 7. Biomarkers Market Value for Efficacy Biomarkers, by Geography, 2021-2030 (USD Billion)
Chart. 8. Biomarkers Market Value for Predictive Biomarkers, by Geography, 2021-2030 (USD Billion)
Chart. 9. Biomarkers Market Value for Surrogate Biomarkers, by Geography, 2021-2030 (USD Billion)
Chart. 10. Biomarkers Market Value for Pharmacodynamics Biomarkers, by Geography, 2021-2030 (USD Billion)
Chart. 11. Biomarkers Market Value for Validation Biomarkers, by Geography, 2021-2030 (USD Billion)
Chart. 12. Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 13. Biomarkers Market Value for Diagnostics, 2021-2030 (USD Billion)
Chart. 14. Biomarkers Market Value for Drug Discovery & Development, by Geography, 2021-2030 (USD Billion)
Chart. 15. Biomarkers Market Value for Personalized Medicine, by Geography, 2021-2030 (USD Billion)
Chart. 16. Biomarkers Market Value for Disease Risk Assessment, by Geography, 2021-2030 (USD Billion)
Chart. 17. Biomarkers Market Value for Others, by Geography, 2021-2030 (USD Billion)
Chart. 18. Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 19. Biomarkers Market Value for Cancer, 2021-2030 (USD Billion)
Chart. 20. Biomarkers Market Value for Infectious Diseases, by Geography, 2021-2030 (USD Billion)
Chart. 21. Biomarkers Market Value for Immune Disorders, by Geography, 2021-2030 (USD Billion)
Chart. 22. Biomarkers Market Value for Neurological Disorders, by Geography, 2021-2030 (USD Billion)
Chart. 23. Biomarkers Market Value for Cardiovascular Disorders, by Geography, 2021-2030 (USD Billion)
Chart. 24. North America Biomarkers Market Value, by Country, 2021-2030 (USD Billion)
Chart. 25. North America Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 26. North America Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 27. North America Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 28. U.S Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 29. U.S Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 30. U.S Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 31. U.S Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 32. Canada Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 33. Canada Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 34. Canada Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 35. Canada Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 36. Mexico Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 37. Mexico Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 38. Mexico Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 39. Mexico Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 40. Europe Biomarkers Market Value, by Country, 2021-2030 (USD Billion)
Chart. 41. Europe Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 42. Europe Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 43. Europe Biomarkers Market Value, End Use Industries, 2021-2030 (USD Billion)
Chart. 44. Europe Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 45. Germany Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 46. Germany Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 47. Germany Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 48. Germany Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 49. U.K Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 50. U.K Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 51. U.K Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 52. U.K Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 53. France Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 54. France Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 55. France Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 56. France Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 57. Italy Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 58. Italy Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 59. Italy Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 60. Italy Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 61. Spain Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 62. Spain Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 63. Spain Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 64. Spain Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 65. RoE Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 66. RoE Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 67. RoE Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 68. RoE Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 69. Asia-Pacific Biomarkers Market Value, by Country, 2021-2030 (USD Billion)
Chart. 70. Asia-Pacific Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 71. Asia-Pacific Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 72. Asia-Pacific Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 73. Asia-Pacific Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 74. China Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 75. China Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 76. China Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 77. China Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 78. India Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 79. India Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 80. India Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 81. India Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 82. Japan Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 83. Japan Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 84. Japan Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 85. Japan Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 86. Rest of APAC Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 87. Rest of APAC Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 88. Rest of APAC Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 89. Rest of APAC Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 90. Latin America Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 91. Latin America Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 92. Latin America Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 93. Latin America Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 94. Brazil Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 95. Brazil Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 96. Brazil Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 97. Brazil Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 98. Argentina Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 99. Argentina Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 100. Argentina Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 101. Argentina Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 102. Middle East and Africa Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 103. Middle East and Africa Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 104. Middle East and Africa Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 105. Middle East and Africa Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 106. Saudi Arabia Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 107. Saudi Arabia Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 108. Saudi Arabia Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 109. Saudi Arabia Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 110. UAE Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 111. UAE Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 112. UAE Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 113. UAE Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 114. Rest of Middle East and Africa Biomarkers Market Value, by Product, 2021-2030 (USD Billion)
Chart. 115. Rest of Middle East and Africa Biomarkers Market Value, by Type, 2021-2030 (USD Billion)
Chart. 116. Rest of Middle East and Africa Biomarkers Market Value, by Application, 2021-2030 (USD Billion)
Chart. 117. Rest of Middle East and Africa Biomarkers Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 118. GE Healthcare: Financials
Chart. 119. GE Healthcare: Products & Services
Chart. 120. GE Healthcare: Recent Developments
Chart. 121. Bio-Rad Laboratories: Financials
Chart. 122. Bio-Rad Laboratories: Products & Services
Chart. 123. Bio-Rad Laboratories: Recent Developments
Chart. 124. Eisai Co. Ltd.: Financials
Chart. 125. Eisai Co. Ltd.: Products & Services
Chart. 126. Eisai Co. Ltd.: Recent Developments
Chart. 127. Abbott Laboratories, Inc.: Financials
Chart. 128. Abbott Laboratories, Inc.: Products & Services
Chart. 129. Abbott Laboratories, Inc.: Recent Developments
Chart. 130. Thermo Fisher Scientific Inc.: Financials
Chart. 131. Thermo Fisher Scientific Inc.: Products & Services
Chart. 132. Thermo Fisher Scientific Inc.: Recent Developments
Chart. 133. Agilent Technologies Inc.: Financials
Chart. 134. Agilent Technologies Inc.: Products & Services
Chart. 135. Agilent Technologies Inc.: Recent Developments
Chart. 136. Roche Diagnostics Limited: Financials
Chart. 137. Roche Diagnostics Limited: Products & Services
Chart. 138. Roche Diagnostics Limited: Developments
Chart. 139. Aushon Biosystem: Financials
Chart. 140. Aushon Biosystem: Products & Services
Chart. 141. Aushon Biosystem: Recent Developments
Chart. 142. Epistem Ltd.: Financials
Chart. 143. Epistem Ltd.: Products & Services
Chart. 144. Epistem Ltd.: Recent Developments
Chart. 145. Siemens AG: Financials
Chart. 146. Siemens AG: Products & Services
Chart. 147. Siemens AG: Recent Developments